Patrick Pritchard
Neurological Surgery · Birmingham, ALNPI 1619901253
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (34.4%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Synthes GmbH at 54.4% of the total. Reporting peaked in 2019 at $3,126 and has fallen 94.3% since, to $178 in 2025.
Across 59 payments — averaging $80.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Synthes GmbH$3K
- Medtronic$593
- Stryker$518
- Globus Medical$508
- Johnson & Johnson$274
- Medical Device Business Services, Inc.$137
- plus $148 from 2 others
Across 1 payment — averaging $34,916 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Vertex$35K
What the payments were for
- Consulting fees$301%
- Speaking & faculty fees$1,50031%
- Travel & lodging$1,64634%
- Food & beverage$1,31628%
- Education$2876%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Synthes GmbH | 3 | $2,600 |
| Medtronic(2 entities) | 39 | $593 |
| Stryker | 2 | $518 |
| Globus Medical(2 entities) | 6 | $508 |
| Johnson & Johnson | 6 | $274 |
| Medical Device Business Services, Inc. | 1 | $137 |
| Nevro Corp. | 1 | $108 |
| Bioventus LLC | 1 | $41 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,778 in reported general payments places this provider in the 70th percentile of 97 neurological surgery providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 57 | $747 |
| Pregabalin | 17 | $249 |
| Oxycodone Hcl | 28 | $163 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Birmingham
- Mark HadleyBirmingham$104K
- Andrew ErwoodBirmingham$85K
- Marshall HollandBirmingham$81K
- Jakub GodzikBirmingham$56K
- Adnan ShahidBirmingham$50K
- Jasmine ThumBirmingham$39K
- Jessica BentleyBirmingham$27K
- John FiveashBirmingham$12K
- Joshua MenendezBirmingham$11K
- Zenko HrynkiwBirmingham$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.